publication date: Mar. 18, 2016

Bunn Wins ASCO Karnofsky Award; Kaelin to Receive Science of Oncology Award

 

The American Society of Clinical Oncology announced the winners of its highest honors, the Special Awards, to be presented during the 2016 ASCO Annual Meeting in June.

“The exceptional accomplishments of each of our awardees reflect their exemplary dedication to furthering cancer research and serving as a beacon of hope to the cancer community,” said Peter Paul Yu, immediate past president of ASCO and chair of the Special Awards Selection Committee. “It is our honor to recognize their enduring contributions with ASCO’s most prestigious awards.”

The 2016 Special Awards Honorees are:

Paul Bunn Jr., the David A. Karnofsky Memorial Award and Lecture.

Bunn is a distinguished professor of medicine and the James Dudley Endowed Professor of Lung Cancer at the University of Colorado School of Medicine. He is the principal investigator of the SPORE in Lung Cancer grant at the University of Colorado. Bunn’s work focuses on identifying novel diagnostics and treatment strategies for lung cancer.

William Kaelin, the Science of Oncology Award and Lecture.

Kaelin is a professor of medicine at the Dana-Farber Cancer Institute and Harvard Medical School, and a senior physician at Brigham and Women’s Hospital. His research focuses on understanding how mutations in tumor-suppressor genes affect cancer development. His work on the VHL protein was instrumental for the subsequent successful development of VEGF inhibitors to treat kidney cancer.

Ethan Dmitrovsky, the ASCO-American Cancer Society … Continue reading 42-11 Bunn Wins ASCO Karnofsky Award; Kaelin to Receive Science of Oncology Award

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.